Jae Park

28PUBLICATIONS
243CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 15, 2026
IL7-Receptor-Targeted CAR T-Cell Therapy for T-Cell Acute Lymphoblastic Leukemia.

|Jun 04, 2026
CAR T-cell Kinetics, Persistence, and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-cell ALL Treated with Obecabtagene Autoleucel in the FELIX Study.

|Aug 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma.

Michael Winkelmann, Sandeep S Raj, Michael D Jain

|Jul 22, 2025
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuit.

Fei Yi, Tal Cohen, Natalie Zimmerman

|Jul 02, 2025
Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies.

Sigrun Einarsdottir, Stephanie Lobaugh, Danny Luan

|Apr 14, 2025
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma.

Alejandro Luna, Sean M Devlin, Kai Rejeski

Pageof 5

Frequent Collaborators

11 joint publications

Maria Lia Palomba

10 joint publications

Miguel-Angel Perales

9 joint publications

Gilles Salles

7 joint publications

Gunjan Shah